Literature DB >> 870626

The choroid plexus in passive serum sickness.

N S Peress, F Miller, W Palu.   

Abstract

Immunofluorescent microscopy of the choroid plexus revealed the presence of rabbit IgG and either rat or mouse C3 in a high percentage of young male Wistar rats and CF1 mice who had received intravenous injections of preformed BSA-rabbit anti BSA complexes over a 3 day period. Electron dense deposits were observed in the basement membrane region of the choroid plexus in these animals. These findings were comparable to those noted in their renal glomeruli. This is the first description of involvement of the choroid plexus in passive immune complex disease. This experimental model is rapidly inducible and should be of value in future pathophysiological studies of this important structure.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 870626     DOI: 10.1097/00005072-197705000-00012

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  4 in total

1.  The effects of chronic serum sickness on albumin distribution and glucose utilization in rat brain.

Authors:  H Nakata; A Shimizu; A Tajima; S Z Lin; K Gruber; E Perillo; N Peress; J Fenstermacher
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 2.  Immunological concepts and the eye: a review of the classical and ocular arthus reactions.

Authors:  L D Ormerod
Journal:  Doc Ophthalmol       Date:  1986       Impact factor: 2.379

3.  Nervous tissue injury induced by immune complexes.

Authors:  N Tsukada; C S Koh; N Yanagisawa; H Tsukagoshi
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

4.  Development of antihuman IgG antibodies and hematologic deficits but not clinical abnormalities in C57BL/6 mice after repeated administration of human intravenous immunoglobulin.

Authors:  David A Loeffler; Lynnae M Smith; Andrea C Klaver; Heather A Brzezinski; Essie I Morrison; Mary P Coffey; Barbara A Steficek; Susan S Cook
Journal:  Comp Med       Date:  2012-02       Impact factor: 0.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.